Obsidian Therapeutics, Inc. OBX
13.29 USD +0.06 (+0.45%)
Nov 4, 2026, 9:46 AM EST
13.29 Day range 13.55
11.52 52-week range 49.97
- YTD
- -24.06%
- 1 year
- -24.06%
Held by funds
12 US ETFs and mutual funds hold OBX · largest positions
Ownership
Held by insiders 0.81%
Held by institutions 27.36%
Float held by institutions 27.58%
Institutions 5
Top institutional holders
No holders on record
Top mutual fund holders
No holders on record
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANG NANCY T | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| EMERALD BIOVENTURES LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| FRIEDMAN MICHAEL R | Director | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| SORENSEN J. MEL | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |
| SORENSEN MELINDA | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |